Becton Dickinson announces FDA Emergency Use Authorization for new COVID-19 diagnostic for use in U.S.

Becton Dickinson, a leading global medical technology company, and BioGX Inc., a molecular diagnostics company, announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a new diagnostic test that will enable hospitals to screen for COVID-19 (coronavirus) on site and get results in...
Read More...